ACE2 and COVID-19: The results showed a significant decrease in ACE2-binding IgG levels from unvaccinated COVID-19 patients after RBD preadsorption, but similar results were not observed in the vaccinated COVID-19 patient group, indicating a significant increase in CR Ab levels in the unvaccinated COVID-19 patient group (Fig. 7D).